AKI Risk Factors Analysis After Intentional Hypotensive Anesthesia
Incidence and Risk Factors Analysis of Acute Kidney Injury (AKI) After Intentional Hypotensive Anesthesia in Orthognathic Surgery Patients Following Enhanced Recovery After Surgery (ERAS) Guidelines
Kaohsiung Medical University Chung-Ho Memorial Hospital
50 participants
Mar 1, 2024
OBSERVATIONAL
Conditions
Summary
This project investigates intentionally hypotensive management such as NTG (nitroglycerin) or NTG+Trandate during general anesthesia in patients undergoing orthognathic surgery. Throughout the entire surgical procedure, blood biochemical and urine monitoring will be conducted. Serum creatinine (Cr) levels, urine analysis, and perioperative monitoring will be utilized as indicators for assessing renal function during the surgery. The objective is to assess its potential renal injury and identify early risk factors for acute kidney injury (AKI). Timely recognition of these factors will allow for the implementation of appropriate intervention strategies, aiding in the prevention of postoperative acute kidney injury. This approach contributes to achieving the goals of Enhanced Recovery After Surgery (ERAS) for surgical patients, promoting faster postoperative recovery.
Eligibility
Inclusion Criteria2
- America society anesthesiologist classification class I to II patients undergoing oro-maxillo-facial surgery
- unlimited mouth opening
Exclusion Criteria7
- patients with arthritis with limited mouth opening
- persistent liver dysfunction
- chronic renal insufficiency
- body mass index ≧35 kg/m2.
- past history of malignant hyperthermia or personal or family history
- diabetes with insulin treatment
- essential hypertension without controlled
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
during surgery, the patient received nitroglycerin infusion or nitroglycerin with labetalol to decrease blood pressure and to decrease blood loss. During the procedures and management, patients were executed of continuously monitoring of arterial blood pressure, hemodynamic changes such as cardiac output, stroke volume variation, peripheral oxygen saturation, and cerebral oximeter.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06259760